What does CUSIP 59935V107 represent in this 13F holders report?

CUSIP 59935V107 is the security identifier for MIST - Milestone Pharmaceuticals Inc. - Common Shares used to aggregate holder disclosures.

How many institutions held MIST - Milestone Pharmaceuticals Inc. - Common Shares in Q3 2022?

43 institutional investors reported MIST - Milestone Pharmaceuticals Inc. - Common Shares for Q3 2022. Use the holders table for investor-level position and value details.

Milestone Pharmaceuticals Inc. - Common Shares (MIST)

CUSIP: 59935V107

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / Common Shares
Shares outstanding: 124,031,000
Total 13F shares: 20,398,285
Share change: +496,568
Total reported value: $187,452,026
Put/Call ratio: 71%
Price per share: $9.19
Number of holders: 43
Value change: +$10,127,011
Number of buys: 24
Number of sells: 15

Quarterly Holders Quick Answers

What is CUSIP 59935V107?
CUSIP 59935V107 identifies MIST - Milestone Pharmaceuticals Inc. - Common Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP 59935V107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of MIST - Milestone Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RTW INVESTMENTS, LP	13F	Company	3.5%	4,315,102	$26,538,000	—	30 Jun 2022	13F
Novo Holdings A/S	13F	Company	2%	2,530,003	$15,560,000	—	30 Jun 2022	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1.8%	2,246,503	$13,816,000	—	30 Jun 2022	13F
Boxer Capital, LLC	13F	Company	1.8%	2,238,861	$13,769,000	—	30 Jun 2022	13F
ORBIMED ADVISORS LLC	13F	Company	1.5%	1,817,521	$11,178,000	—	30 Jun 2022	13F
Ikarian Capital, LLC	13F	Company	1.1%	1,379,422	$8,194,000	—	30 Jun 2022	13F
MORGAN STANLEY	13F	Company	1.1%	1,318,173	$8,107,000	—	30 Jun 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.1%	1,358,362	$8,069,000	—	30 Jun 2022	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.8%	987,411	$6,073,000	—	30 Jun 2022	13F
Lion Point Capital, LP	13F	Company	0.76%	948,570	$5,634,000	—	30 Jun 2022	13F
Bleichroeder LP	13F	Company	0.41%	512,500	$3,044,000	—	30 Jun 2022	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.37%	457,200	$2,812,000	—	30 Jun 2022	13F
BARCLAYS PLC	13F	Company	0.17%	211,710	$1,302,000	—	30 Jun 2022	13F
Eversept Partners, LP	13F	Company	0.12%	147,165	$905,065	—	30 Jun 2022	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.11%	132,501	$815,000	—	30 Jun 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.06%	75,346	$448,000	—	30 Jun 2022	13F
Paul F. Truex	3/4/5	Director	— mixed-class rows	81,897 mixed-class rows	$383,548	—	31 May 2022	3/4/5
STATE STREET CORP	13F	Company	0.02%	21,608	$128,000	—	30 Jun 2022	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	18,500	$114,000	—	30 Jun 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.01%	18,233	$108,000	—	30 Jun 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	17,576	$104,000	—	30 Jun 2022	13F
NATIONAL BANK OF CANADA /FI/	13F	Company	0.01%	14,842	$88,000	—	30 Jun 2022	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.01%	13,717	$84,000	—	30 Jun 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.01%	12,004	$74,000	—	30 Jun 2022	13F
LMR Partners LLP	13F	Company	0.01%	11,732	$72,000	—	30 Jun 2022	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0.01%	10,500	$64,575	—	30 Jun 2022	13F
JPMORGAN CHASE & CO	13F	Company	0%	3,539	$21,000	—	30 Jun 2022	13F
Urban Wealth Management, LLC	13F	Company	0%	3,194	$20,000	—	30 Jun 2022	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	2,879	$18,000	—	30 Jun 2022	13F
UBS Group AG	13F	Company	0%	1,016	$6,000	—	30 Jun 2022	13F

Institutional Holders of Milestone Pharmaceuticals Inc. - Common Shares (MIST) as of Q3 2022

As of 30 Sep 2022, Milestone Pharmaceuticals Inc. - Common Shares (MIST) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,398,285 shares. The largest 10 holders included RTW INVESTMENTS, LP, VR Adviser, LLC, RA CAPITAL MANAGEMENT, L.P., Novo Holdings A/S, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, Ikarian Capital, LLC, BOXER CAPITAL, LLC, GREAT POINT PARTNERS LLC, and Paradigm Biocapital Advisors LP. This page lists 43 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.